THERAVANCE BIOPHARMA R&D IP, LLC et al v. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED > Summary
Court Case Number 1:23-cv-02843
Filing Date May 24, 2023
Termination Date Jun 26, 2023
Court New Jersey District Court
Status Statistical Closing
JudgesAnn Marie Donio
Plaintiff Attorneys
9Theravance Biopharma
Attorney Name: Arnold B. Calmann
Saiber
Theravance Biopharma
Attorney Name: Katherine A. Escanlar
Saiber
Theravance Biopharma
Attorney Name: Mary W. Bourke
Womble Bond Dickinson
Theravance Biopharma
Attorney Name: Dana K. Severance
Womble Bond Dickinson
Theravance Biopharma
Attorney Name: Ben Bourke
Womble Bond Dickinson
Theravance Biopharma
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Theravance Biopharma
Attorney Name: Kevin E. Warner
Rakoczy Molino Mazzochi Siwik
Theravance Biopharma
Attorney Name: Joseph T. Jaros
Rakoczy Molino Mazzochi Siwik
Theravance Biopharma
Attorney Name: Matthew V. Anderson
Rakoczy Molino Mazzochi Siwik
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11484531 | Methods for treating chronic obstructive pulmonary disease | Nov 1, 2022 |
| 11008289 | Crystalline freebase forms of a biphenyl compound | May 18, 2021 |
| 10550081 | Crystalline freebase forms of a biphenyl compound | Feb 4, 2020 |
